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While the determination of the three-dimensional structure of a 
protein is a landmark on the way to understand its function, one key 
element is still missing, and that is the element of motion. Proteins are 
in an ongoing state of motion easily exceeding mere thermal 
fluctuation and in most cases this conformational dynamics is the 
foundation enabling a protein to carry out its physiological function 
in the first place [1,2]. Part of the molecular mechanical branch of 
modelling techniques [2], molecular dynamics (MD) simulations 
numerically investigate the motion of a system of particles under the 
influence of internal (interactions between atoms) and external forces 
such as temperature or pressure [3] as well as optional additional 
forces in steered or targeted MD [4]). A key ingredient of MD 
simulations is the potential energy function that relates energy to 
structure using harmonic, periodic, Coulomb and Lennard Jones-like 
potentials to calculate the forces acting on each particle in the system. 
Employing Newton’s second law of motion MD simulation uses this 
information to predict each particle’s motion during the next few 
femtoseconds. Repeating this step millions of times, a trajectory of all 
atoms in the system over time is generated [1-3,5]. Complementing 
and extending the nearly static experimental 3D data MD simulations 
bring back for a limited time the element of motion, permitting to 
cast a glimpse on the dynamics of  a  (e.g. membrane)  protein and  its  


















experiments today. Moreover, by bringing together a system's 
components to study their interplay, MD simulations offer a literally 
synthetic approach of investigation instead of dissecting the system to 
deduce its functional mechanism. 
Since the first MD studies published by Alder and Wainwright 
more than 50 years ago [6,7], the first MD simulation of a protein 
carried out by McCammon and co-workers 20 years later [8], the first 
simulation of a lipid bilayer by Van der Ploeg and Berendsen in 1983 
[9], and the first simulation study of a bilayer-embedded membrane 
protein by Edholm et al. 17 years ago [10], MD simulations have 
benefited enormously from the impressive advances made in computer 
and software development, now permitting the investigation of 
simulation systems of the size of 105 – 106 atoms on a nanosecond to 
millisecond time scale [11-13]. Beyond providing high resolution 
conformational samples of proteins and other biomolecules, MD 
simulations have also recently been employed as a tool to compare 
and categorize proteins, adding internal conformational dynamics as a 
third level of protein classification next to amino acid sequence and 
protein structure [14]. 
A key question of any MD simulation is whether the amount of 
conformational sampling achieved is adequate for the problem under 
investigation. Whereas for small individual molecules appropriately 
long simulations can be performed permitting a sufficient sampling of 
the available degrees of freedom, for large molecules like proteins only 
a partial sampling of conformational space is possible today [15]. 
However, partial sampling can already yield valuable insights into 
protein function providing e.g. a set of configurations near the X-ray 
structure, based on which conformational sub-populations comprising 
the entire reaction cycle can be determined [11,16-19]. Moreover, 
transportation pathways and interaction sites can be elucidated by 
analyzing e.g. the dynamics of solvent molecules [20-23]. New 
mutagenesis candidates can be identified as they undergo for example 
specific distance changes throughout the reaction cycle [16-19,24] or 
impacting protein activity [1,11,16,20-22]. To enhance 
conformational sampling additional forces can be used biasing the 
simulation in a steered manner [24-34] or the simulation can be 
performed running several independent copies of the same system 
differing only in the random seed numbers used in generating the 
starting velocities. While stating the respective simulation approaches  
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employed in the studies presented in this review, we refer the reader to 
the original publications for further-going in-depth information and 
discussion of the individual methodologies, approximations made and 
their adequateness for the questions investigated. 
 
 
The discovery, development and clinical exploitation of 
antibiotics count among the most significant medical advances in 
history. However, antibiotics lose their efficiency after a period of 
months to years [35-37], eventually producing new strains of resistant 
bacteria, as the continuous application of antibiotics wipes out the 
cells in a bacteria population sensitive to the drug given. At the same 
time this effect creates perfect survival conditions for the fraction of 
bacteria immune to the pharmaceuticals applied. With old antibiotics 
losing their efficiency faster than new ones can be developed [38], a 
detailed understanding of the molecular basis of microbial multi-drug 
resistance is paramount for modern biomedical research. The main 
mechanisms of action underlying antibiotics resistance include the 
alteration of the drug, the alteration of the drug target as well the 
reduction of antibiotics concentration inside the bacterium by 
lowering influx into and/or enhancing the extrusion out of the 
organism [39,40].  
A major way by which Gram-negative bacteria achieve an 
increased extrusion is through an over-expression of multi-drug efflux 
pumps of the resistance nodulation division (RND) protein super 
family [42], preventing drug access to the target molecule [43,44]. 
RND transporters function as transiently assembled protein 
complexes constituting (a) an inner membrane proton / substrate 
antiporter, functioning as engine and active transporter of the 
assembled pump (figure 1, IMA); (b) an access-regulated outer 
membrane channel acting as efflux duct for substrate trafficking 
(figure 1, ED) and (c) an inner membrane-anchored adaptor protein 
(figure 1, AP) coupling IMA and ED, enhancing pump activity [45]. 
Whereas crystal structures have recently become available for all 
components of three different but structurally homologue RND 
efflux pumps in Escherichia coli (AcrAB-TolC and CusBA-C) 
[41,46-57] and Pseudomonas aeruginosa (MexAB-OprM) [41,58-
60], the structure of the assembled pump is unknown. The 
visualization of the assembled IMA-AP-ED complex in figure 1 
shows a docking model based on biochemical cross-linking data [41]. 
Whereas this model comprises three APs interacting with IMA and 
ED, recent studies suggest that MexA and AcrA form a funnel-like 
hexamer when binding to their respective EDs [61-63] similar to the 
IMA-AP crystal structure of the heavy metal efflux transporter CusBA 
[57]. 
Figure 1. RND efflux pumps comprise three different components (left) assembling into a functional complex (right). Using the proton concentration gradient 
over the inner membrane (IM) the inner membrane proton / substrate antiporter (IMA) acts as engine and active transporter of the efflux pump, expelling 
substrates (S) out of the cell via the access-regulated efflux duct (ED) in the outer cell membrane (OM). In the assembled pump IMA and ED are coupled by an 
inner membrane-anchored adaptor protein (AP), whose actual stochiometry and location in the assembled pump is not known for all RND efflux transporters. 
To visualize the structure of the assembled IMA-ED-AP complex we used a docking model based on biochemical cross-linking data [41]. The references in the 
figure represent simulation studies of the respective efflux pump component discussed in this review. 
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2. EFFLUX PUMP SIMULATIONS 
 
With the advent of high-resolution crystal structures, computer 
simulations have grown into a vivid field of research in investigating 
the functional mechanisms of efflux pump-mediated antibiotics 
resistance, employing a palette of computational methodologies 
including elastic network normal mode analyses [59,64], multiple 
basin [65] and MD simulations. In this review we focus on 
computational studies of RND efflux transporter components using 
molecular dynamics simulations. Reflecting the general structure of an 
RND efflux pump (figure 1), we organized the review part in three 
sections, summarizing the simulation studies reported for the inner 
membrane antiporter (section 2.1), the outer membrane efflux duct 
(section 2.2) and the adaptor protein (section 2.3). 
 
Engine and active transporter of the assembled efflux pump, the 
inner membrane proton / drug antiporter is a homo-trimer whose 
individual protomers are organized in three distinctive sections, each 
fulfilling different functions (figure 1, IMA). Whereas energy 
conversion via proton conduction takes place in the trans-membrane 
domain (TMD), substrate recruitment and transport mainly occur in 
the periplasmic porter domain (PD) which in turn is coupled through 
the docking domain (DD) to the outer membrane ED (figure 1), or 
to the hexameric assembly of APs in the constituted pump. A 
characteristic IMA feature is a structural asymmetry among the 
monomers, each trapped in a different conformation, interpreted as 
reaction cycle intermediates “Loose” / “access” (monomer A), 
“Tight” / “binding” (monomer B) and “Open” / “extrusion” 
(monomer C) in a peristaltic pump functional mechanism [55,56,66]. 
Figure 2. On a 50 ns time scale WT AcrB displays a TMD-internal water distribution suggesting three alternative routes of proton transfer where the key 
residue-comprising core region (CR) is connected to bulk water via one cytoplasmic (X) and three periplasmic water channels (E1-3) merging in single conflux 
region (CF) (a). Dynamic and monomer-specific TMD hydration was found in agreement with the location and impact of known point mutations (b) with bulk 
water access regulated by four groups of gating residues (c). Adapted from [20], modified.   
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IMA simulation studies published so far have focused on two 
questions: How are protons transported (section 2.1.1)? How is 
substrate transported (section 2.1.2)? As at the time of writing MD 
studies of the heavy metal efflux transporter CusA have not been 
reported yet, this section focuses on investigations carried out for 
AcrB and MexB. 
 
As proton conduction in proteins occurs along hydrogen-bonded 
networks of polar residues and water molecules [67] in a Grotthuss-
like mechanism [68-71], knowledge of the protein-internal water 
distribution and interacting residues allows drawing conclusions to 
possible pathways of proton conduction [21,22,72-76].  
In AcrB the protein-internal water distribution is experimentally 
unknown and so far five TMD residues have been identified whose 
mutation to alanine leads to a function loss of 90% or more [52,77-
80]. Furthermore, for each monomer an intermediate-specific 
protonation scenario has been proposed based on the available X-ray 
structures [81]. To predict TMD hydration and potential new key 
residue candidates Fischer and Kandt performed a series of 6 x 50 ns 
independent and unbiased atomistic MD simulations of asymmetric, 
wild-type (WT) AcrB in a phospholipid / water environment, 
simulating each monomer in its currently proposed protonation 
scenario [20]. Using the MD trajectories to compute spatial residence 
probabilities of TMD-internal water, the authors find that TMD 
water is organized in one cytoplasmic and up to three periplasmic 
water channels connecting the known five key residues to bulk phase, 
suggesting three alternative routes of proton transfer (figure 2a). 
Reflecting the different protonation scenarios in each monomer, the 
TMD water distribution is reported to be intermediate-specific and 
correlating well with the location of 15 experimentally tested residues 
[52,77-80] and their respective impact on AcrB function (figure 2b). 
Using different time resolutions in computing the water densities, the 
authors find the water channels dynamic and their bulk water access 
regulated by four groups of gating residues in a combination of side 
chain re-orientations preceded by intermediate-specific shifts of α-
helices enabling or disabling opening or closure of the gating residues 
(figure 2c). 
 
Computational studies assessing the question of substrate 
transport in the proton/drug antiporter focus on the dynamics of the 
porter domain, using unbiased or steered MD in the absence (section 
2.1.2.1) or presence of substrate (section 2.1.2.2). 
 
2.1.2.1 IMA dynamics in the absence of substrate 
Focusing on PD ground state dynamics in the absence of 
substrate, Fischer and Kandt [16] carried out a series of 6 x 100 ns 
independent and unbiased atomistic MD simulations of asymmetric 
WT AcrB in a phospholipid membrane / water environment to 
address the question why all 34 currently available AcrB crystal 
structures [47,51-53,55,56,82] exhibit very similar PD 
conformations. Displaying Cα RMSDs below 1 Å after superposition 
to the simulation starting structure [55], in all crystal structures the 
outer access or proximal binding pocket PBP [47,53] is open in 
monomers A and B but closed in C, while the inner deep, distal or 
hydrophobic binding pocket HBP [47,53] is open in B but closed in 
A and C. At the same time the exit region of the PD substrate 
transport channel (PDx) is closed in monomers A and B but open in 
monomer C (figure 3). Observing opening and closing motions of the 
PBP in monomers A and B (figure 3a), a predominantly closed HBP 
in all monomers (figure 3b) as well as an opening and closing PDx in 
monomer C (figure 3c), Fischer and Kandt proposed that the X-ray 
conformations are stabilized by a component absent in the 
simulations, suggesting bound but unresolved substrate molecules as 
possible explanation. Based on the observed conformational dynamics 
the study further suggests that each of the known three reaction cycle 
intermediates occurs in at least two variants and the Thr676 loop 
independently regulates porter domain access likely playing a key role 
in substrate transport. If the proximal binding pocket dynamics have 
an inhibiting effect on AcrB pump activity by lowering the life time of 
substrate-accessible conformations, the observed dynamics could 
provide a structural explanation for the AcrB activity-enhancing effect 
of the adaptor protein AcrA [45] stabilizing PC1 and PC2 
subdomain orientations.  
 
2.1.2.2 IMA dynamics in presence of substrate 
The picture extracted from the crystallographic data is an 
invaluable starting point to understand substrate-IMA interactions. 
However, a complete picture must include the dynamics of all the 
parts involved, i.e., transporter, substrate, and solvent. Unfortunately, 
experiments aimed at estimating the efflux kinetics are quite complex 
and possible so far only for-lactams antibiotics [83,84]. In addition, 
despite the strong effect of efflux on the minimum inhibitory 
concentrations (MICs) of substrates, it is very difficult to 
quantitatively determine the contribution of drug transport among all 
factors affecting the susceptibility of a cell to antibiotics [83,84]. 
Computer simulations are thus an important tool to complement and 
interpret experiments on kinetics [85]. A first question concerns the 
plausibility of the functional rotation. By mimicking the 
conformational transitions of the AcrB reaction cycle via targeted 
molecular dynamics (tMD) [31], Schulz et al. [86] observed in 4 
independent simulations a displacement of doxorubicin by 8 Å from 
the HBP towards PDx. Concurrently, a zipper-like closure of the 
HBP was observed, supporting the peristaltic pump mechanism 
proposed on the basis of the crystal structures [47,51-53,55,56,82]. 
Insights into the behaviour of the solvent during the imposed 
functional rotation were achieved in additional unbiased [87] and 
tMD simulations [88], detecting a directed water flow towards the 
PDx. This direction is defined by the conformational changes of PD. 
However, Schulz et al. never observed a complete extrusion of 
doxorubicin. One possibility to explain this is that the passage of the 
drug through PDx might be, at least partially, diffusion-driven, and 
thus should occur on a time scale much larger than that captured by 
all-atom MD simulations. In addition, the motion of the drug might 
further be enhanced by the presence of other substrates. Finally, how 
other proteins components absent in the simulations affect transport 
needs to be understood better, in the long run leading to eventually 
taking into account the entire efflux pump. Similar results were 
obtained by Feng and co-workers [87] who investigated the in silico 
dynamics of AcrB in complex with erythromycin, rifampicin and 
minocycline. The authors found that rifampicin and erythromycin, 
bound to the A monomer, made a unidirectional peristaltic movement 
towards the extrusion funnel of ToIC, which was facilitated by water 
flux within the channel of AcrB. Minocycline in the B monomer 
moved from the distal binding pocket towards the gate of the central 
funnel.  
A key point to the comprehension of efflux systems regards the 
link between affinity and efficient extrusion: how high should a 
compound’s affinity to the transporter be to make it a good substrate? 
A substrate should remain inside IMA long enough to be extruded 
but its affinity should not be too high, otherwise the extrusion might 
be overly energy-demanding. Site-directed mutagenesis studies 
provided  the  experimental basis  to  shed  some  light  on  this  issue.  
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Bohnert et al. [89] systematically mutated HBP phenylalanine residues 
into alanine and determined the mutants’ susceptibility to various 
antimicrobials. Interestingly, the F610A point mutation displayed the 
most significant impact on the substrates’ MICs, while replacing other 
HBP phenylalanines with alanines had smaller and more variable 
effects. Puzzling in these results is that F610 does not directly interact 
with doxorubicin and minocycline in the crystal structure [51] and it 
is practically not involved in the zipper-like movement of the HBP 
residues responsible of the departure of doxorubicin from the pocket 
as described above [86]; and doxorubicin displays one of the most 
pronounced MIC reductions in the F610A mutant [89]. Combining 
several computational techniques, Vargiu and co-workers [90] 
provided a possible explanation for the role of F610, as in the mutant 
the authors found doxorubicin sliding deeply into the binding pocket, 
thus increasing the strength of the protein-compound interaction and 
making extrusion hardly feasible. Indeed, during subsequent tMD 
simulations of the AcrB reaction cycle, in the mutant doxorubicin was 
either not extruded from the binding site or displaced along a 
direction other than the one associated with extrusion. In WT AcrB 
F610 provides the appropriate balance between affinity and energy 
requirement to extrude a substrate. The study indicates how subtle 
interactions determine the functionality of multidrug transporters, 
since decreased transport might not be simplistically correlated to 
decreased substrate binding affinity [90].  
Using a truncated protein model restricted to the porter and 
docking domain, Vargiu and Nikaido simulated AcrB in complex 
with substrates, non-substrates, and inhibitors previously docked to 
the HBP [91]. While all substrates tested remained bound to the 
HBP, the authors found that non-substrates, predicted by the docking 
procedure to bind outside the HBP, remained there during 50 - 80 ns 
of unbiased MD. Moreover, the two AcrB inhibitors (Phe-Arg-β-
naphthylamide and 1-(1-naphtylmethyl)-piperazine), located by 
docking runs inside the HBP, tended to leave the pocket at least 
partially, straddling the G-rich loop whose flexibility has been 
indicated by Yamaguchi and co-workers to be essential for the 
functioning of AcrB [53]. Importantly, MD simulations by Feng et al. 
[87] confirmed that the mutations of G616P and G619P could 
prevent the movement of the G-loop. 
Whereas at the time of writing 34 crystal structures have been 
reported for AcrB [47,51-53,55,56,82], only one X-ray structure of 
the apo protein has been published for its P. Aeruginosa homologue 
MexB [60]. With a sequence identity of 69.8% MexB and AcrB are 
structurally very similar, sharing several conformational key features. 
However, in monomer A the proteins differ in their respective PBP 
conformation, which is open in AcrB but closed in MexB, hindering 
substrates to enter. It is currently unknown whether the different PBP 
conformation in AcrB and MexB is an effect of the crystallization 
procedure, an indication of a different monomer involvement in the 
extrusion process, or an evidence supporting the high PBP flexibility 
proposed in [16].  
Imipenem (IMI) and meropenem (MER) of the carbapenem 
compound family have been the most active broad-spectrum 
antibiotics against P. aeruginosa infections [93], but resistant strains 
have appeared [93-95]. Several studies evaluating compounds’ MICs 
Figure 3. On a 200 ns time scale WT AcrB’s drug-transporting porter domain is highly flexible, displaying opening and closing motions of the proximal binding 
pocket in monomers A and B (a), a closure of the further inward located hydrophobic binding pocket (HBP) in B (b) and an opening and closing of the proposed 
exit of the drug transport channel in C (c). Adapted from [16], modified.    
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indicated that MexAB-OprM affects the activity of MER, while that 
of IMI is essentially insensitive to over-expression of the pump [96-
99]. To identify the molecular basis of the underlying carbapenem–
efflux-pump interactions Collu and co-workers performed docking 
and 8 standard 50ns-long MD simulations using a truncated model of 
MexB [92]. Configurations assumed by the compounds during the 
simulations are reported in figure 4. Whereas MER showed high 
affinity to the HBP, assuming there conformations that prelude to 
efficient transduction towards the extrusion channel (figure 4c), IMI 
did not bind to the HBP with good affinity, exploring geometries 
similar to those reported in AcrB mutants for poorly transducing 
substrates (figure 4d) [90]. The authors suggest two main reasons for 
these behaviours. First, the bulky and more hydrophobic groups in 
MER favour interactions with the aromatic-hydrophobic environment 
of HBP, whereas the more flexible and more hydrophilic tail of IMI 
does not. Secondly, the interaction with the solvent plays a role. 
Despite the compounds are highly solvated in both PBP and HBP, the 
water dynamics around MER is significantly different in HBP than in 
the bulk solvent. On the contrary, IMI shows the same interactions 










Once recruited by the IMA, the substrate is transported out of the 
cell via the ED in the assembled pump (figure 1). Essentially 
resembling the shape of a hollow cylinder, the ED occurs in at least 
two different states, blocking the passage of substrate, e.g. when not 
interacting with an IMA, and permitting the trafficking of substrate 
for example as part of the assembled RND efflux pump. The 
underlying gating mechanism has been the main focus of ED 
simulation studies, which at the time of writing have been reported 
for E. coli TolC and P. aeruginosa OprM. 
Computational studies of TolC focused on MD simulations 
comparing wild type (WT) and mutants in the outer periplasmic 
bottleneck region [100,101], WT ground state dynamics [19] as well 
as elastic network normal mode analyses exploring possible opening 
mechanisms using TolC and OprM crystal structures [102]. In a 20 
ns MD study of WT and Y362F+R367S TolC Vaccaro and co-
workers reported the mutant exhibiting heightened flexibility in the 
periplasmic mouth region while for the extracellular loops a gating 
function was proposed based on the observed closing motions [101]. 
In a series of 20 – 30 ns MD simulations of WT, Y362PF+R367E 
and Y362F+R367D TolC Schulz and Kleinekathöfer observed WT-
like closed periplasmic mouth conformations stabilized by potassium 
ions coordinated by T152, D153, and E/D367 in the mutant 
structures [100]. Only when the potassium binding sites were emptied 
using an outer electric field a BNII (green rectangle in figure 5a) 
opening trend was observed.  
Simulating WT TolC (figure 5a) in a series of 9 150 - 300 ns 
unbiased and independent atomistic MD runs, Raunest and Kandt 
[19] observed free opening and closing motions on extracellular side 
(figure 5b), opening and sodium-induced closing motions of the outer 
periplasmic bottleneck region [103] (figure 5c, d green) whereas the 
inner periplasmic bottleneck [104] remained in a crystal structure-like 
closed conformation unless all NaCl was removed from the system 
(figure 5c, d, red). In that case a re-opening of the outer bottleneck 
occurred, concurrent with a beginning opening trend of the inner 
bottleneck. The free opening and closing of the extracellular loops 
suggested the absence of a gating mechanism on this side as well as 
hinted at the possibility of designing a novel group of TolC-directed 
drugs specifically targeting the protein interior. Additionally, the 
observed conformational dynamics on the opposite side indicates that 
TolC is locked only on periplasmic side in a sodium-dependent 
manner. In a similar study Koch et al. [18] sampled the ground state 
dynamics of WT OprM in a series of 5 independent, unbiased 200ns 
atomistic MD runs. Like TolC, the OprM simulations suggested 
unilateral access regulation, with the protein opening and closing 
freely towards the extracellular while on periplasmic side only the 
Asp416 region is involved in channel gating. Contrary to TolC, no 
evidence was found suggesting a Na-dependent lock mechanism in 
OprM, although for OprM too new sodium binding sites were 
reported.       
 
Though the third component of the efflux systems, the adaptor 
protein (figure 1, AP) (AcrA for E.coli, MexA for P.aeruginosa), has 
also been the object of thorough experimental study, several aspects 
remain unclear, especially regarding the interplay among and the 
assembling of the three efflux pump components [50,105-111]. 
Anchored to the inner membrane, APs extend into the periplasm 
acting as a central linker between IMA and ED and play a critical role 
in the transport event itself. However, the apparently simple question 
of how many AP proteins are necessary in the assembled functional 
pump has not received a clear-cut answer. Recent studies suggest that 
both MexA and AcrA show propensity to form a funnel-like hexamer 
when APs bind to the respective EDs [61,62], coinciding with the 
stochiometry seen in the crystal structure of the structurally 
homologue heavy metal efflux transporter CusA solved in complex 
with its AP CusB [57]. 
At the time of writing two AP MD studies have been published: 
one on MexA [112], the other on AcrA [113]. Vaccaro et al. [112] 
investigated MexA in the absence of the membrane anchor and 
without a large part of the membrane proximal (MP) domain, at that 
time not resolved. Principal components analysis of the 25ns-long 
MD trajectories identified a hinge-bending motion and a rotation of 
the α-helical hairpin relative to the other domains of MexA as the two 
dominant motions. According to the root mean square fluctuation of 
each residue from its  time  averaged  position the largest fluctuations  
Figure 4. Configurations assumed by MER and IMI in MexB according to 
50ns-long MD simulations. The residues of MexB are in licorice colored 
according to the region they belong to (blue, PBP; orange, HBP). Panels a 
and b refer to the compounds in PBP, c and d in HBP. The starting 
configurations of the carbapenems are represented in green licorice, 
those at the end of the simulations in atom-code colored licorice. Arrows 
denote the orientation of the compounds in panels a, b, and c. In panel d 
we report the shift of IMI. Adapted from [92], modified. 
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are for the loop between the two α-helices forming the hairpin, and 
for two loops in the β-barrel domain. Interestingly, the first two loops 
(i.e. the hairpin and one of the two β-domain loops) appear to be 
correlated in their motion. Further, the motion of the helical-hairpin 
loop appears to correlate with the C-terminal region. Of interest, this 
region has been shown experimentally to be involved in AP / IMA 
interactions [114]. These motions indicate considerable flexibility, 
which is likely to be exploited in the adaptor function of MexA 
during the assembly and opening of functional pores during pump 
activity. The simulations offered first interesting insights into the 
dynamical role of AP, although the study was limited by short 
simulation times, an incomplete AP structure, no membrane 
environment and by the fact that only a single MexA protein was 
considered. Note that the importance of the MP domain has been 
demonstrated by the recently solved crystal structure of MexA, in 
which the MP domain adopts two distinct orientations with respect 
to the other part of the protein [41]. 
Performing 20 ns MD simulations of WT and mutant AcrA in 
an aqueous environment under different pH conditions, including the 
homology-modelled MP but lacking the membrane-anchoring N-
Terminus, Wang and co-workers [113] showed that AcrA flexibility 
largely stems from the α-hairpin and MP domains, whereas the lipoyl 
and β-barrel domains form a relatively rigid module. The authors 
further reported that both point mutations and pH influence protein 
dynamics, with pH 5 conditions reducing conformational flexibility, 
in agreement with electron paramagnetic resonance experiments [115]. 
Situated in the ß-barrel domain H285 was identified as regulatory key 
of the pH-induced changes in conformational flexibility whose 
reduction could be interpreted as favouring intermolecular packing 
and reducing the entropy cost of oligomerization. Furthermore, as 
AcrA/B binding affinity is pH-dependent [61], periplasmic pH 
changes accompanying the drug efflux could also act as a signal 
regulating the assembly of the functional AcrAB−TolC complex. 
3. CONCLUDING REMARKS 
 
In this review we provide a survey on the application of atomistic 
simulations to study the molecular bases of RND efflux pump-based 
antibiotics resistance, summarizing the recent studies investigating the 
conformational dynamics of the inner membrane proton/drug 
antiporters AcrB and MexB, the outer membrane efflux ducts TolC 
and OprM as well as the inner membrane-anchored adaptor proteins 
AcrA and MexA. With the first relevant simulation study published 
merely seven years ago, the computational investigation of efflux 
pump-meditated multidrug resistance is still a young field of research 
that has only just begun to gain momentum. Nonetheless, some 
interesting findings have already been reported and it will be exciting 
to see what the future holds for this branch of computational 
research, already addressing biological questions on a time and system 
complexity scale that would have been considered impossible only a 
few years ago. 
 
Figure 5. On a 300 ns time scale WT TolC (a) opens and closes freely on extracellular side (b) and in the region of the outer periplasmic bottleneck BNII at 
Glu365 while the inner bottleneck BNI remains closed unless all NaCl is removed from the system (c, d). Adapted from [19], modified. 
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